JAMES PATRINELY to Antineoplastic Agents, Immunological
This is a "connection" page, showing publications JAMES PATRINELY has written about Antineoplastic Agents, Immunological.
Connection Strength
1.655
-
The Role of Anti-PD-1/PD-L1 in the Treatment of Skin Cancer. BioDrugs. 2020 Aug; 34(4):495-503.
Score: 0.649
-
Survivorship in immune therapy: Assessing toxicities, body composition?and health-related quality of life among long-term survivors treated with antibodies to programmed death-1 receptor and its ligand. Eur J Cancer. 2020 08; 135:211-220.
Score: 0.645
-
Extended Follow-Up of Chronic Immune-Related Adverse Events Following Adjuvant Anti-PD-1 Therapy for High-Risk Resected Melanoma. JAMA Netw Open. 2023 08 01; 6(8):e2327145.
Score: 0.200
-
Immune checkpoint inhibitor toxicities: systems-based approaches to improve patient care and research. Lancet Oncol. 2020 08; 21(8):e398-e404.
Score: 0.162